Trypanosoma cruzi Virulence Factors for the Diagnosis of Chagas’ Disease
- 20 September 2019
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 5 (11) , 1813-1819
Abstract
trans-Sialidase and cruzipain are important virulence factors from Trypanosoma cruzi, the etiological agent of Chagas disease, that have highly antigenic domains in their structure and were reported as potential tools for diagnosis of the illness. The aim of the present study is to assess the possibility of using cruzipain and the catalytic domain of trans-sialidase in a Surface Plasmon Resonance-based immunosensor for the diagnosis of chronic Chagas disease. Immunoassays carried out with canine sera verified that cruzipain allows the detection of anti-Trypanosoma cruzi antibodies whereas recombinant trans-sialidase did not yield specific detections, due to the high dilutions of serum used in the immunoassays that hinder the possibility to sense the specific low titer antibodies. The developed cruzipain-based biosensor, whose price per assay is comparable to a commercial enzyme-linked immunosorbent assay (ELISA), was successfully applied for the rapid quantification of specific antibodies against Trypanosoma cruzi in fresh human sera showing an excellent agreement with ELISA.Keywords
Funding Information
- Consejo Nacional de Investigaciones Cient?ficas y T?cnicas (PIP 0671)
- Agencia Nacional de Promoci?n Cient?fica y Tecnol?gica (PICT 2016-0679)
- Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo (2017/26058-6)
- Fundaci?n Bunge y Born
- Instituto Nacional de Ci?ncia e Tecnologia de Bioanal?tica
This publication has 34 references indexed in Scilit:
- Virulence factors of Trypanosoma cruzi: who is who?Microbes and Infection, 2012
- Highly Effective Serodiagnosis for Chagas' DiseaseClinical and Vaccine Immunology, 2010
- Comparison of Recombinant Trypanosoma cruzi Peptide Mixtures versus Multiepitope Chimeric Proteins as Sensitizing Antigens for ImmunodiagnosisClinical and Vaccine Immunology, 2009
- Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18Clinical and Vaccine Immunology, 2005
- Serodiagnosis of Chronic and Acute Chagas' Disease with Trypanosoma cruzi Recombinant Proteins: Results of a Collaborative Study in Six Latin American CountriesJournal of Clinical Microbiology, 2004
- Enzyme-Linked Immunoassay Using Recombinant trans -Sialidase of Trypanosoma cruzi Can Be Employed for Monitoring of Patients with Chagas' Disease after Drug TreatmentClinical and Vaccine Immunology, 2003
- A Functional Network of Intramolecular Cross‐Reacting Epitopes Delays the Elicitation of Neutralizing Antibodies toTrypanosoma cruzi trans‐SialidaseThe Journal of Infectious Diseases, 2002
- Mechanism of Aggregates Generated by Heating Human Serum.Biological and Pharmaceutical Bulletin, 1996
- Antibodies Inhibiting Trypanosoma cruzi Trans-Sialidase Activity In Sera From Human InfectionsThe Journal of Infectious Diseases, 1994
- Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6)Clinical and Experimental Immunology, 1994